{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T11:12:50Z","timestamp":1764587570376},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychosomatics"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.psym.2012.01.005","type":"journal-article","created":{"date-parts":[[2012,5,31]],"date-time":"2012-05-31T19:01:14Z","timestamp":1338490874000},"page":"595-600","source":"Crossref","is-referenced-by-count":15,"title":["Cabergoline Associated with First Episode Mania"],"prefix":"10.1016","volume":"53","author":[{"given":"Yael T.","family":"Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander Z.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose M.","family":"deAsis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Ferrando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmala","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.psym.2012.01.005_bib2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4065\/80.8.1050","article-title":"Medication-induced hyperprolactinemia","volume":"80","author":"Molitch","year":"2005","journal-title":"Mayo Clinic Proceedings"},{"issue":"1\/3","key":"10.1016\/j.psym.2012.01.005_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0327(01)00432-3","article-title":"The Stanley Foundation Bipolar Treatment Outcome Network","volume":"67","author":"Suppes","year":"2001","journal-title":"J Affect Disord"},{"key":"10.1016\/j.psym.2012.01.005_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity, and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry: J Mental Sci"},{"issue":"4","key":"10.1016\/j.psym.2012.01.005_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archgenpsychiatry.2010.15","article-title":"Longitudinal course of bipolar I disorder: duration of mood episodes","volume":"67","author":"Solomon","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"10.1016\/j.psym.2012.01.005_bib6","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archpsyc.1978.01770350059005","article-title":"Secondary mania: manic syndromes associated with antecedent physical illness or drugs","volume":"35","author":"Krauthammer","year":"1978","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1016\/j.psym.2012.01.005_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.psym.2012.01.005_bib8","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/mds.23177","article-title":"Clozapine for medication-related pathologic gambling in Parkinson disease","volume":"25","author":"Rotondo","year":"2010","journal-title":"Movement Dis: Official J Movement Dis Soc"},{"issue":"4","key":"10.1016\/j.psym.2012.01.005_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1176\/appi.neuropsych.19.4.473","article-title":"Pathologic gambling associated with cabergoline therapy in a patient with a pituitary prolactinoma","volume":"19","author":"Davie","year":"2007","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"10.1016\/j.psym.2012.01.005_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5694\/j.1326-5377.2009.tb02289.x","article-title":"Pathologic gambling and hypersexuality in cabergoline-treated prolactinoma","volume":"190","author":"Falhammar","year":"2009","journal-title":"Med J Australia"},{"issue":"1","key":"10.1016\/j.psym.2012.01.005_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00702-006-0560-0","article-title":"A history of dopamine agonists","volume":"114","author":"Horowski","year":"2007","journal-title":"J Neural Transm"},{"year":"2005","series-title":"Drug discovery: a history","author":"Sneader","key":"10.1016\/j.psym.2012.01.005_bib13"},{"year":"2010","series-title":"Manual of clinical psychopharmacology","author":"Schatzberg","key":"10.1016\/j.psym.2012.01.005_bib14"},{"year":"2009","series-title":"The American Psychiatric Publishing textbook of psychopharmacology","author":"Schatzberg","key":"10.1016\/j.psym.2012.01.005_bib15"},{"issue":"8","key":"10.1016\/j.psym.2012.01.005_bib16","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.4088\/JCP.v68n0810","article-title":"Pramipexole in psychiatry: a systematic review of the literature","volume":"68","author":"Aiken","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.psym.2012.01.005_bib17","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00019052-200312001-00002","article-title":"Dopamine agonists, receptor selectivity and dyskinesia induction in Parkinson's disease","volume":"16","author":"Jenner","year":"2003","journal-title":"Curr Opin Neurol"},{"issue":"10","key":"10.1016\/j.psym.2012.01.005_bib18","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1586\/14737175.7.10.1391","article-title":"Role of dopamine agonists in Parkinson's disease: an update","volume":"7","author":"Bonuccelli","year":"2007","journal-title":"Expert Rev Neurother"},{"issue":"14","key":"10.1016\/j.psym.2012.01.005_bib19","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","article-title":"A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea","volume":"331","author":"Webster","year":"1994","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.psym.2012.01.005_bib20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.parkreldis.2011.01.009","article-title":"Dopamine agonist-triggered pathologic behaviors: surveillance in the PD clinic reveals high frequencies","volume":"17","author":"Hassan","year":"2011","journal-title":"Parkinsonism and Related Dis"},{"issue":"1","key":"10.1016\/j.psym.2012.01.005_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11102-005-5079-0","article-title":"The epidemiology of prolactinomas","volume":"8","author":"Ciccarelli","year":"2005","journal-title":"Pituitary"},{"key":"10.1016\/j.psym.2012.01.005_bib22","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1192\/bjp.150.5.662","article-title":"Epidemiology of puerperal psychoses","volume":"150","author":"Kendell","year":"1987","journal-title":"Br J Psychiatry: J Mental Sci"},{"issue":"6","key":"10.1016\/j.psym.2012.01.005_bib23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2165\/00002018-200932060-00004","article-title":"Behavioral adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention","volume":"32","author":"Antonini","year":"2009","journal-title":"Drug Safety: Int J Med Toxicol Drug Exp"},{"issue":"4","key":"10.1016\/j.psym.2012.01.005_bib24","first-page":"26","article-title":"Evidence for frontal-subcortical circuit abnormalities in bipolar affective disorder","volume":"2","author":"Marchand","year":"2005","journal-title":"Psychiatry"},{"year":"2007","series-title":"Manic-depressive illness: bipolar disorders and recurrent depression","author":"Goodwin","key":"10.1016\/j.psym.2012.01.005_bib25"},{"issue":"2","key":"10.1016\/j.psym.2012.01.005_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/15622970510029768","article-title":"Imaging monetary reward in pathologic gamblers","volume":"6","author":"Hollander","year":"2005","journal-title":"World J Biol Psychiatry"},{"issue":"1\/3","key":"10.1016\/j.psym.2012.01.005_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0010-0277(94)90018-3","article-title":"Insensitivity to future consequences following damage to human prefrontal cortex","volume":"50","author":"Bechara","year":"1994","journal-title":"Cognition"},{"issue":"6","key":"10.1016\/j.psym.2012.01.005_bib28","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1037\/0735-7044.99.6.1066","article-title":"Enhanced frustrative nonreward effect following 6-hydroxydopamine lesions of the lateral septum in the rat","volume":"99","author":"Taghzouti","year":"1985","journal-title":"Behav Neurosci"},{"issue":"12","key":"10.1016\/j.psym.2012.01.005_bib29","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archpsyc.63.12.1386","article-title":"Modeling sensitization to stimulants in humans: an [11C]raclopride\/positron emission tomography study in healthy men","volume":"63","author":"Boileau","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.psym.2012.01.005_bib30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ng0196-78","article-title":"Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking","volume":"12","author":"Ebstein","year":"1996","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.psym.2012.01.005_bib31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1017\/S0033291700009132","article-title":"Dextroamphetamine-induced arousal in human subjects as a model for mania","volume":"16","author":"Jacobs","year":"1986","journal-title":"Psychol Med"},{"issue":"4","key":"10.1016\/j.psym.2012.01.005_bib32","first-page":"341","article-title":"L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients","volume":"2","author":"Goodwin","year":"1970","journal-title":"Biol Psychiatry"},{"issue":"7","key":"10.1016\/j.psym.2012.01.005_bib33","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1176\/appi.ajp.157.7.1108","article-title":"Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients","volume":"157","author":"Anand","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.psym.2012.01.005_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF02253582","article-title":"D1 dopamine receptor binding in mood disorders measured by positron emission tomography","volume":"106","author":"Suhara","year":"1992","journal-title":"Psychopharmacology (Berlin)"},{"issue":"2","key":"10.1016\/j.psym.2012.01.005_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0165-1781(00)00249-3","article-title":"Measurement of inter-episode impulsivity in bipolar disorder","volume":"101","author":"Swann","year":"2001","journal-title":"Psychiatry Res"},{"issue":"3","key":"10.1016\/j.psym.2012.01.005_bib36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1176\/appi.ajp.158.3.420","article-title":"Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder","volume":"158","author":"McElroy","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.psym.2012.01.005_bib37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1176\/ajp.141.2.215","article-title":"Affective disorders among pathological gamblers seeking treatment","volume":"141","author":"McCormick","year":"1984","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.psym.2012.01.005_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1176\/appi.ajp.162.1.137","article-title":"Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?","volume":"162","author":"Hollander","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psym.2012.01.005_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/573252","article-title":"New insights in the management of antipsychotics in the treatment of schizophrenia in a patient with prolactinoma: a case report and review of the literature","volume":"2010","author":"Santos Andrade","year":"2010","journal-title":"Case Report Med"},{"issue":"4","key":"10.1016\/j.psym.2012.01.005_bib40","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1176\/appi.psy.50.4.317","article-title":"Evidence for the partial dopamine-receptor agonist aripiprazole as a first-line treatment of psychosis in patients with iatrogenic or tumorogenic hyperprolactinemia","volume":"50","author":"Hoffer","year":"2009","journal-title":"Psychosomatics"},{"issue":"5","key":"10.1016\/j.psym.2012.01.005_bib41","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0033-3182(10)70718-0","article-title":"Management of psychosis associated with a prolactinoma: case report and review of the literature","volume":"51","author":"Ali","year":"2010","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1016\/j.psym.2012.01.005_bib42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4088\/JCP.v65n0207","article-title":"Cabergoline treatment of risperidone-induced hyperprolactinemia: a pilot study","volume":"65","author":"Cavallaro","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.psym.2012.01.005_bib43","first-page":"121","article-title":"[Risperidone-induced symptomatic hyperprolactinemia in youth with schizophrenia: efficacy and tolerability of cabergoline treatment]","volume":"158","author":"Pollice","year":"2007","journal-title":"La Clinica Terapeutica"},{"issue":"11","key":"10.1016\/j.psym.2012.01.005_bib44","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/BF03345068","article-title":"Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders","volume":"23","author":"Tollin","year":"2000","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.psym.2012.01.005_bib45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/104454601317261618","article-title":"Treatment of risperidone-induced hyperprolactinemia with a dopamine agonist in children","volume":"11","author":"Cohen","year":"2001","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"10.1016\/j.psym.2012.01.005_bib46","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.genhosppsych.2007.11.002","article-title":"Cabergoline-induced psychotic exacerbation in schizophrenic patients","volume":"30","author":"Chang","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"issue":"2","key":"10.1016\/j.psym.2012.01.005_bib47","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"6115","key":"10.1016\/j.psym.2012.01.005_bib48","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/bmj.1.6115.790-a","article-title":"Bromocriptine-induced mania?","volume":"1","author":"Brook","year":"1978","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.psym.2012.01.005_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0368-2315(06)76376-1","article-title":"[Post partum mania induced by bromocriptine: a case report]","volume":"35","author":"Misdrahi","year":"2006","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"5","key":"10.1016\/j.psym.2012.01.005_bib50","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0163-8343(91)90041-T","article-title":"Mania precipitated by prednisone and bromocriptine","volume":"13","author":"Fisher","year":"1991","journal-title":"Gen Hosp Psychiatry"},{"issue":"7","key":"10.1016\/j.psym.2012.01.005_bib51","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1176\/ajp.138.7.980","article-title":"Treated mania exacerbated by bromocriptine","volume":"138","author":"Johnson","year":"1981","journal-title":"Am J Psychiatry"},{"issue":"6111","key":"10.1016\/j.psym.2012.01.005_bib52","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/bmj.1.6111.510-a","article-title":"Bromocriptine-induced mania?","volume":"1","author":"Vlissides","year":"1978","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.psym.2012.01.005_bib53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/014107688708000620","article-title":"Psychiatric side effects of bromocriptine therapy for postpartum galactorrhoea","volume":"80","author":"Kemperman","year":"1987","journal-title":"J Royal Soc Med"},{"issue":"8","key":"10.1016\/j.psym.2012.01.005_bib54","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/070674378703200810","article-title":"Cyclothymic disorder and bromocriptine: predisposing factors for postpartum mania?","volume":"32","author":"Lake","year":"1987","journal-title":"Can J Psychiatry"},{"issue":"8382","key":"10.1016\/j.psym.2012.01.005_bib55","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(84)91359-X","article-title":"Response to bromocriptine distinguishes bipolar from unipolar depression","volume":"1","author":"Silverstone","year":"1984","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.psym.2012.01.005_bib56","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.genhosppsych.2007.05.004","article-title":"A case of mania after long-term use of quinagolide","volume":"29","author":"Vinkers","year":"2007","journal-title":"Gen Hosp Psychiatry"}],"container-title":["Psychosomatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318212000060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318212000060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T08:09:32Z","timestamp":1594195772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033318212000060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0033318212000060"],"URL":"https:\/\/doi.org\/10.1016\/j.psym.2012.01.005","relation":{},"ISSN":["0033-3182"],"issn-type":[{"type":"print","value":"0033-3182"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}